Arbutus Biopharma
ABUS
ABUS
55 hedge funds and large institutions have $212M invested in Arbutus Biopharma in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 18 closing their positions.
Holders
55
Holders Change
-8
Holders Change %
-12.7%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
17
Reduced
14
Closed
18
Calls
$1.4M
Puts
$864K
Net Calls
+$537K
Net Calls Change
-$571K
Top Buyers
1 |
1
Primecap Management
Pasadena,
California
|
$17.3M |
2 |
HM
2
HealthCor Management
New York
|
$13.1M |
3 |
SM
3
Sabby Management
Miami Beach,
Florida
|
$4.42M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$4.6M |
5 |
5
Axa
Paris,
France
|
$4.86M |